Societal CDMO(REPH)
2.09 0.00 0.0%
| 今开：0.0 | 昨收：2.09 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.17926555E8 |
Societal CDMO的最新讨论
牛唐2019-03-18 17:34
$Recro制药(REPH)$ 的N1539治疗术后疼痛在去年吃了CRL，主要原因是数据及次要终点的选择不符合FDA的预期，这个月24号第二次申请，过的概率有，但不会很大查看全文
![[加]](http://js.xueqiu.com/ugc/images/face/emoji_52_plus.png?v=1 "[加]"){kind=small}
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
Societal CDMO的公告
$Recro Pharma, Inc.(REPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-09 AccNo: 0001564590-18-012102 Size: 8 MB 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-05-09 AccNo: 0001193125-18-156750 Size: 113 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-05-07 AccNo: 0001193125-18-153757 Size: 32 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ 美东时间 2018-05-09 盘前 披露财报，预期EPS -0.68 网页链接
$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-04-30 AccNo: 0001193125-18-140714 Size: 35 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma, Inc.(REPH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-23 AccNo: 0001193125-18-094214 Size: 731 KB 网页链接
$Recro Pharma, Inc.(REPH)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-23 AccNo: 0001193125-18-094200 Size: 1 MB 网页链接
$Recro Pharma, Inc.(REPH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-23 AccNo: 0001193125-18-094214 Size: 731 KB 网页链接
$Recro Pharma, Inc.(REPH)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-23 AccNo: 0001193125-18-094200 Size: 1 MB 网页链接
$Recro Pharma, Inc.(REPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-03-21 AccNo: 0000935836-18-000186 Size: 50 KB 网页链接